These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32524727)

  • 21. Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis.
    Keller C
    Ther Apher Dial; 2003 Jun; 7(3):345-9. PubMed ID: 12924611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics Approach Identifies Factors Associated With the Response to Low-Density Lipoprotein Apheresis Therapy in Patients With Steroid-Resistant Nephrotic Syndrome.
    Kuribayashi-Okuma E; Shibata S; Arai S; Ota T; Watanabe S; Hisaki H; Okazaki T; Toda T; Uchida S
    Ther Apher Dial; 2016 Apr; 20(2):174-82. PubMed ID: 26771065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic apheresis in peripheral and retinal circulatory disorders.
    Ramunni A; Brescia P; De Fino G; Piscopo G; Gesualdo L
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):41-4. PubMed ID: 22528133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Italian multicenter study on low-density lipoprotein apheresis Working Group 2009 survey.
    Stefanutti C; Morozzi C; Di Giacomo S;
    Ther Apher Dial; 2013 Apr; 17(2):169-78. PubMed ID: 23551673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of lipoprotein apheresis on PCSK9 levels.
    Julius U; Milton M; Stoellner D; Rader D; Gordon B; Polk D; Waldmann E; Parhofer KG; Moriarty PM
    Atheroscler Suppl; 2015 May; 18():180-6. PubMed ID: 25936324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
    Gordon BR; Kelsey SF; Dau PC; Gotto AM; Graham K; Illingworth DR; Isaacsohn J; Jones PH; Leitman SF; Saal SD; Stein EA; Stern TN; Troendle A; Zwiener RJ
    Am J Cardiol; 1998 Feb; 81(4):407-11. PubMed ID: 9485128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current insights into the German Lipoprotein Apheresis Registry (GLAR) - Almost 5 years on.
    Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Roeseler E; Heigl F; Grützmacher P; Blume H;
    Atheroscler Suppl; 2017 Nov; 30():50-55. PubMed ID: 29096861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease.
    Yataco AR; Corretti MC; Gardner AW; Womack CJ; Katzel LI
    Am J Cardiol; 1999 Mar; 83(5):754-8. PubMed ID: 10080432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.
    Heigl F; Hettich R; Lotz N; Reeg H; Pflederer T; Osterkorn D; Osterkorn K; Klingel R
    Atheroscler Suppl; 2015 May; 18():154-62. PubMed ID: 25936320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes.
    Hohenstein B; Julius U; Lansberg P; Jaeger B; Mellwig KP; Weiss N; Graehlert X; Roeder I; Ramlow W
    Atheroscler Suppl; 2017 Nov; 30():180-186. PubMed ID: 29096835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of different treatment regimens in a case of homozygous familial hypercholesterolemia.
    Palcoux JB; Meyer M; Jouanel P; Vanlieferinghen P; Malpuech G
    Ther Apher; 2002 Apr; 6(2):136-9. PubMed ID: 11982954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
    Koga N
    Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre.
    Mickiewicz A; Borowiec-Wolna J; Bachorski W; Gilis-Malinowska N; Gałąska R; Raczak G; Chmara M; Wasąg B; Jaguszewski MJ; Fijałkowski M; Gruchała M
    Cardiol J; 2019; 26(6):669-679. PubMed ID: 30234904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical review on the use of lipid apheresis and rheopheresis for treatment of peripheral arterial disease and the diabetic foot syndrome.
    Weiss N
    Semin Dial; 2012; 25(2):220-7. PubMed ID: 22175277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study).
    Schettler VJ; Muellendorff F; Schettler E; Platzer C; Norkauer S; Julius U; Neumann CL
    Ther Apher Dial; 2019 Oct; 23(5):467-473. PubMed ID: 30663261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.
    Gordon BR; Kelsey SF; Bilheimer DW; Brown DC; Dau PC; Gotto AM; Illingworth DR; Jones PH; Leitman SF; Prihoda JS
    Am J Cardiol; 1992 Oct; 70(11):1010-6. PubMed ID: 1414897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
    Igarashi K; Tsuji M; Nishimura M; Horimoto M
    J Clin Apher; 2004; 19(1):11-6. PubMed ID: 15095396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART).
    Yamaguchi H; Lee YJ; Daida H; Yokoi H; Miyano H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F
    Chem Phys Lipids; 1994 Jan; 67-68():399-403. PubMed ID: 8187240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.